We are live on ! Find out more
WE

Wealth Effects Portfolio holdings

AUM $282M
1-Year Est. Return 62.81%
This Fund
S&P 500
This Quarter Est. Return
+10.63%
1 Year Est. Return
+62.81%
3 Year Est. Return
+160.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$175M
AUM Growth
+$11.7M
Cap. Flow
+$906K
Cap. Flow %
0.52%
Top 10 Hldgs %
37.76%
Holding
209
New
26
Increased
49
Reduced
95
Closed
18

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$4.92M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$2M
3
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$1.7M
4
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$1.48M
5
VUG icon
Vanguard Growth ETF
VUG
+$1.15M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.62M
2
STE icon
Steris
STE
+$1.75M
3
PFE icon
Pfizer
PFE
+$970K
4
ROKU icon
Roku
ROKU
+$840K
5
STIP icon
iShares 0-5 Year TIPS Bond ETF
STIP
+$790K

Sector Composition

Rank Sector Weight
1 Healthcare 26.42%
2 Technology 17.53%
3 Financials 8.13%
4 Industrials 5.54%
5 Communication Services 5.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBRX icon
176
ImmunityBio
IBRX
$7.8B
$144K 0.08%
28,500
– –
ET icon
177
Energy Transfer Partners
ET
$69.5B
$119K 0.07%
10,000
– –
FCT
178
First Trust Senior Floating Rate Income Fund II
FCT
$249M
$102K 0.06%
+10,723
New +$105K
JMIA
179
Jumia Technologies
JMIA
$806M
$101K 0.06%
31,375
-750
-2% -$3.38K
STXS icon
180
Stereotaxis
STXS
$164M
$99.9K 0.06%
48,260
-400
-0.8% -$782
SCYX icon
181
SCYNEXIS
SCYX
$44.5M
$96K 0.05%
7,694
-3,250
-30% -$57.5K
ICCC icon
182
ImmuCell
ICCC
$101M
$95.5K 0.05%
15,650
– –
BFX
183
DELISTED
BowFlex Inc.
BFX
$90.3K 0.05%
59,008
-5,656
-9% -$8.99K
AUTL
184
Autolus Therapeutics
AUTL
$389M
$80.3K 0.05%
42,250
-1,350
-3% -$3.41K
BCS icon
185
Barclays
BCS
$95.2B
$78K 0.04%
10,000
-25,000
-71% -$182K
ONDS icon
186
Ondas Inc
ONDS
$3.79B
$74.7K 0.04%
47,000
-5,600
-11% -$16.5K
CATX icon
187
Perspective Therapeutics
CATX
$336M
$27.2K 0.02%
11,000
– –
HYFM icon
188
Hydrofarm Holdings
HYFM
$3.24M
$26.4K 0.02%
1,703
-1,076
-39% -$24.6K
PVLA
189
Palvella Therapeutics
PVLA
$2.12B
$22.6K 0.01%
271
-205
-43% -$16.5K
IMDX
190
Insight Molecular Diagnostics
IMDX
$152M
$13K 0.01%
2,025
-525
-21% -$5.79K
AKBA icon
191
Akebia Therapeutics
AKBA
$376M
$10.6K 0.01%
18,316
– –
BKT icon
192
BlackRock Income Trust
BKT
$339M
– –
-3,500
Closed -$43K
CIBR icon
193
First Trust NASDAQ Cybersecurity ETF
CIBR
$14.3B
– –
-7,527
Closed -$290K
F icon
194
Ford
F
$56.5B
– –
-10,472
Closed -$117K
FIVN icon
195
FIVE9
FIVN
$1.93B
– –
-2,880
Closed -$216K
FNF icon
196
Fidelity National Financial
FNF
$14B
– –
-12,144
Closed -$423K
FTGC icon
197
First Trust Global Tactical Commodity Strategy Fund
FTGC
$2.91B
– –
-17,870
Closed -$453K
GGT
198
Gabelli Multimedia Trust
GGT
$176M
– –
-16,951
Closed -$104K
HMC icon
199
Honda
HMC
$37.3B
– –
-9,457
Closed -$204K
KEYS icon
200
Keysight
KEYS
$53.4B
– –
-2,105
Closed -$331K
5 6 7
8
9

Similar funds

SIC
Samalin Investment Counsel Chappaqua, New York $282M AUM 16.72% 1-Year Est. Return
DRD
Dennis R. Delaney $282M AUM 16.32% 1-Year Est. Return
II
INCA Investments Miami, Florida $282M AUM 42.53% 1-Year Est. Return
3CP
3G Capital Partners New York $282M AUM 22.21% 1-Year Est. Return
MFG
Monte Financial Group Guilford, Connecticut $282M AUM 14.97% 1-Year Est. Return
TC
TAGStone Capital Charlotte, North Carolina $283M AUM 14.51% 1-Year Est. Return
UFAC
Urban Financial Advisory Corp Chicago, Illinois $283M AUM 13.45% 1-Year Est. Return
TPW
Tiller Private Wealth Bethlehem, Pennsylvania $281M AUM 16.29% 1-Year Est. Return

Wealth Effects's Q4 2022 Portfolio in Review

As of Q4 2022, Wealth Effects held 209 positions worth $175M, up 7.1% from $164M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Wealth Effects's Q4 2022 filing shows 26 new, 49 increased, 95 reduced and 18 closed positions. Its largest new stake was Vanguard Total Stock Market ETF: 25,507 shares worth $4.88M. The largest sale was Apple, an estimated $2.62M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

  • Wealth Effects's largest Q4 2022 buy was Vanguard Total Stock Market ETF: 25,507 shares worth $4.88M.
  • Wealth Effects added most to Vanguard Short-Term Corporate Bond ETF in Q4 2022, an estimated $670K increase.
  • Wealth Effects's biggest Q4 2022 reduction was Apple, cutting an estimated $2.62M.
  • Wealth Effects fully exited Steris in Q4 2022, selling an estimated $1.75M.
  • Wealth Effects's ten largest holdings make up 38% of its $175M portfolio in Q4 2022.
  • Wealth Effects opened 26 new positions and closed 18 in Q4 2022.
  • Wealth Effects's portfolio value rose 7.1% quarter-over-quarter to $175M.

Based on Wealth Effects's 13F filing for Q4 2022, filed 2 Feb 2023.